American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation

Gastroenterology. 2019 Jan;156(1):218-226. doi: 10.1053/j.gastro.2018.07.016. Epub 2018 Oct 16.

Authors

Seth D Crockett¹, Katarina B Greer², Joel J Heidelbaugh³, Yngve Falck-Ytter⁴, Brian J Hanson⁵, Shahnaz Sultan⁵; American Gastroenterological Association Institute Clinical Guidelines Committee

Affiliations

¹ Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina. Electronic address: sethc@med.unc.edu.
² Division of Gastroenterology and Liver Disease, University Hospitals Cleveland Medical Center, Cleveland, Ohio.
³ Departments of Family Medicine and Urology, University of Michigan Medical School, Ann Arbor, Michigan.
⁴ Division of Gastroenterology, Case Western Reserve University and Louis Stokes Veterans Affairs Medical Center, Cleveland, Ohio.
⁵ Division of Gastroenterology, University of Minnesota and Minneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota.

PMID: 30340754
DOI: 10.1053/j.gastro.2018.07.016

No abstract available

Publication types

Practice Guideline
Review

MeSH terms

Analgesics, Opioid / adverse effects*
Consensus
Constipation / chemically induced
Constipation / diagnosis
Constipation / drug therapy*
Constipation / physiopathology
Defecation / drug effects*
Gastroenterology / standards*
Humans
Laxatives / adverse effects
Laxatives / therapeutic use*
Narcotic Antagonists / adverse effects
Narcotic Antagonists / therapeutic use*
Recovery of Function
Secretagogues / adverse effects
Secretagogues / therapeutic use*
Serotonin Receptor Agonists / adverse effects
Serotonin Receptor Agonists / therapeutic use*
Treatment Outcome

Substances

Analgesics, Opioid
Laxatives
Narcotic Antagonists
Secretagogues
Serotonin Receptor Agonists